Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel and Carboplatin in Advanced or Recurrent MMMT of the Uterus
NCT00502203Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Aug 2001
- Primary completion
- Nov 2010
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, carboplatin in malignant mixed Mullerian tumor (MMMT), sponsored by University of Texas MD Anderson Cancer Center. Started Aug 2001; status: completed.
02
Drugs
paclitaxelcarboplatin
03
Conditions
malignant mixed Mullerian tumor (MMMT)
Beyond the preview
Go deeper on NCT00502203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00502203.